Spectroscopic Characterization, DFT Studies, Molecular Docking and Cytotoxic Evaluation of 2‐(2‐Bromophenyl)‐1H‐Benzimidazole: A Potent Anti‐Breast Cancer Agent

Ähnliche Einträge

• Computational and Spectroscopic Insights Into 4‐Methoxychalcone as a Potential Acetylcholinesterase Inhibitor: A DFT and Molecular Docking Approach
  von: S. Sumathi, et al.
  Veröffentlicht: (2025)
• DFT Computation, Spectroscopic, Hirshfeld Surface, Docking and Topological Analysis on 2,2,5‐Trimethyl‐1,3‐Dioxane‐5‐Carboxylic Acid as Potent Anti‐Cancer Agent
  von: J. Senthil kumar, et al.
  Veröffentlicht: (2024)
• Spectroscopic, DFT, In Silico, and Estimation of Biological Activity of 2,4‐Dichloro‐6,7‐Dimethoxyquinazoline as a Potential Anti‐Alzheimer's Disease Therapeutic Agent
  von: Karthikeyan Asokan, et al.
  Veröffentlicht: (2024)
• Spectroscopic, Quantum Chemical, Docking, and Simulation Studies of a Benzothiazole‐Based Derivative With Anti‐Breast Cancer Potential
  von: N. Siva Jyothi, et al.
  Veröffentlicht: (2026)
• Spectroscopic, computational, cytotoxicity, and docking studies of 6‐bromobenzimidazole as anti‐breast cancer agent
  von: V. S. Kunjumol, et al.
  Veröffentlicht: (2024)